Prestige Consumer Healthcare Inc. Stock price

Equities

PBH

US74112D1019

Pharmaceuticals

Real-time Estimate Cboe BZX 03:59:32 2024-03-28 pm EDT 5-day change 1st Jan Change
72.63 USD 0.00% Intraday chart for Prestige Consumer Healthcare Inc. -1.83% +18.49%
Sales 2024 * 1.14B Sales 2025 * 1.16B Capitalization 3.61B
Net income 2024 * 217M Net income 2025 * 231M EV / Sales 2024 * 4.12 x
Net Debt 2024 * 1.07B Net Debt 2025 * 826M EV / Sales 2025 * 3.82 x
P/E ratio 2024 *
16.8 x
P/E ratio 2025 *
15.7 x
Employees 560
Yield 2024 *
-
Yield 2025 *
-
Free-Float 88.65%
More Fundamentals * Assessed data
Dynamic Chart
Prestige Consumer Healthcare Insider Sold Shares Worth $1,766,665, According to a Recent SEC Filing MT
Prestige Consumer Healthcare Insider Sold Shares Worth $2,051,874, According to a Recent SEC Filing MT
Prestige Consumer Healthcare Insider Sold Shares Worth $368,184, According to a Recent SEC Filing MT
Prestige Consumer Healthcare's Fiscal Q3 Earnings, Revenue Increase; Raises 2024 Earnings Guidance; Shares Gain MT
Transcript : Prestige Consumer Healthcare Inc., Q3 2024 Earnings Call, Feb 08, 2024
North American Morning Briefing : S&P 500 to Open -2- DJ
Earnings Flash (PBH) PRESTIGE CONSUMER HEALTHCARE Reports Q3 Revenue $282.7M, vs. Street Est of $280.4M MT
Earnings Flash (PBH) PRESTIGE CONSUMER HEALTHCARE Reports Q3 EPS $1.06, vs. Street Est of $1.04 MT
Prestige Consumer Healthcare Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Prestige Consumer Healthcare Inc. Revises Earnings Guidance for the Year of Fiscal 2024 CI
Prestige Consumer Healthcare Unit Recalls 2 Lots of Ting Antifungal Spray Liquid on High Levels of Benzene MT
Prestige Consumer Healthcare Unit Recalls One Lot of Anesthetic Spray Due to Benzene Presence MT
Prestige Consumer Healthcare Unit Recalls 2 Lots of Antifungal Spray Powder Due to High Levels of Benzene MT
Transcript : Prestige Consumer Healthcare Inc., Q2 2024 Earnings Call, Nov 02, 2023
Prestige Consumer Healthcare Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
More news

Latest transcript on Prestige Consumer Healthcare Inc.

1 day+0.88%
1 week-1.04%
Current month+4.38%
1 month+3.97%
3 months+17.41%
6 months+21.70%
Current year+18.64%
More quotes
1 week
71.40
Extreme 71.4
74.60
1 month
68.76
Extreme 68.76
75.31
Current year
57.95
Extreme 57.9497
75.31
1 year
52.90
Extreme 52.9
75.31
3 years
42.70
Extreme 42.7
75.31
5 years
27.40
Extreme 27.4
75.31
10 years
25.94
Extreme 25.94
75.31
More quotes
Managers TitleAgeSince
Chief Executive Officer 60 10-12-05
Director of Finance/CFO 49 16-09-11
Chief Operating Officer 63 18-03-31
Members of the board TitleAgeSince
Director/Board Member 68 15-07-31
Director/Board Member 71 21-02-01
Director/Board Member 63 -
More insiders
Date Price Change Volume
24-03-28 72.56 -0.09% 96 642
24-03-27 72.63 +0.87% 228,596
24-03-26 72 +0.57% 197,563
24-03-25 71.59 -2.27% 210,329
24-03-22 73.25 -0.87% 219,291

Delayed Quote Nyse, March 27, 2024 at 04:00 pm EDT

More quotes
Prestige Consumer Healthcare Inc. is engaged in the development, manufacturing, marketing, sales and distribution of over-the-counter (OTC) health and personal care products to mass merchandisers, drug, food, dollar, convenience, club and e-commerce stores in North America (the United States and Canada) and in Australia and certain other international markets. The Company operates through two segments: North American OTC Healthcare and International OTC Healthcare. Its diverse portfolio of brands include Monistat and Summer's Eve women's health products, BC and Goody's pain relievers, Clear Eyes and TheraTears eye care products, DenTek specialty oral care products, Dramamine motion sickness treatments, Fleet enemas and glycerin suppositories, Chloraseptic and Luden's sore throat treatments and drops, Compound W wart treatments, Little Remedies pediatric over-the-counter products, Boudreaux's Butt Paste diaper rash ointments, Nix lice treatment, Debrox earwax remover, and others.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
72.63 USD
Average target price
74.33 USD
Spread / Average Target
+2.35%
Consensus
  1. Stock
  2. Equities
  3. Stock Prestige Consumer Healthcare Inc. - Nyse